Pulmonary involvement is highly prevalent in individuals with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), affecting 82.7% of patients with granulomatosis with polyangiitis ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2017" report to their offering. Pharmaceutical and Healthcare ...
The prophylactic efficacy of TMP-SMX was significantly higher in subgroups with baseline lymphopenia, azotemia, microscopic polyangiitis, or relapsed AAV. Prophylactic use of ...
AAV is a multi-organ disease, which can be complex and may vary from person to person. Types of AAV include granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic ...
AAV is a multi-organ disease, which can be complex and may vary from person to person. Types of AAV include granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic ...
The FDA has approved an expanded indication of AstraZeneca’s benralizumab (Fasenra) in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare, ...
European Medicines Agency’s (EMA) human medicines committee (CHMP) has started a review of Tavneos (avacopan), following emerging information that raises questions regarding the data integrity of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results